Literature DB >> 9808820

The cancer information service research consortium: an emerging laboratory for cancer control research.

A C Marcus1, M E Morra, E Bettinghaus, L A Crane, G Cutter, S Davis, B K Rimer, C Thomsen, R B Warnecke.   

Abstract

The Cancer Information Service (CIS) was established in 1975 by the National Cancer Institute (NCI) to provide accurate, up-to-date information about cancer to the nation. Although the CIS has in the past served as a venue for cancer communications research, up until very recently the research capacity of the CIS was underutilized. In 1993, this situation changed dramatically with funding from the NCI to form the Cancer Information Service Research Consortium (CISRC). In this article the CISRC is described for the first time, including its research agenda and administrative structure. Early indications from the CISRC suggest that the CIS can serve as one of the premiere laboratories in the country for cancer communications and cancer control research. Several factors are suggested for the early success of the CISRC in sustaining this collaborative effort with the CIS. The progress that has been made by the CISRC could provide a useful model for other large health information programs to maximize their contributions to behavioral science and health promotion research, as well as to establish their own program of policy-relevant research. Copyright 1998 American Health Foundation and Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9808820     DOI: 10.1006/pmed.1998.0245

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

1.  Relationships among Internet health information use, patient behavior and self efficacy in newly diagnosed cancer patients who contact the National Cancer Institute's NCI Atlantic Region Cancer Information Service (CIS).

Authors:  Linda Fleisher; Sarah Bass; Sheryl Burt Ruzek; Nancy McKeown-Conn
Journal:  Proc AMIA Symp       Date:  2002

2.  A call for action in survivorship research and care.

Authors:  R Doll; A Kazanjian; K Smillie; A Ward; M Chasen
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

3.  The development and preliminary testing of a multimedia patient-provider survivorship communication module for breast cancer survivors.

Authors:  Kuang-Yi Wen; Suzanne M Miller; Annette L Stanton; Linda Fleisher; Marion E Morra; Alexandra Jorge; Michael A Diefenbach; Mary E Ropka; Alfred C Marcus
Journal:  Patient Educ Couns       Date:  2012-07-07

4.  Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication.

Authors:  Melissa A Simon; Ludmila Cofta-Woerpel; Veenu Randhawa; Priya John; Gregory Makoul; Bonnie Spring
Journal:  Patient Educ Couns       Date:  2010-01-08

5.  The NCI's Cancer Information Service's Research Continuum Framework: integrating research into cancer education practice (1999-2004).

Authors:  Linda Fleisher; Julie Kornfeld; Sharon Davis; Marion E Morra; Linda Squiers
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

6.  The National Cancer Institute's Cancer Information Service: a premiere cancer information and education resource for the nation.

Authors:  Mary Anne Bright
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

7.  Cancer patient and survivor research from the cancer information service research consortium: a preview of three large randomized trials and initial lessons learned.

Authors:  Alfred C Marcus; Michael A Diefenbach; Annette L Stanton; Suzanne M Miller; Linda Fleisher; Peter C Raich; Marion E Morra; Rosemarie Slevin Perocchia; Zung Vu Tran; Mary Anne Bright
Journal:  J Health Commun       Date:  2013-02-28

8.  Responding to a significant recruitment challenge within three nationwide psychoeducational trials for cancer patients.

Authors:  Annette L Stanton; Marion E Morra; Michael A Diefenbach; Suzanne M Miller; Rosemarie Slevin Perocchia; Peter C Raich; Linda Fleisher; Kuang-Yi Wen; Zung Vu Tran; Nihal E Mohamed; Roshini George; Mary Anne Bright; Alfred C Marcus
Journal:  J Cancer Surviv       Date:  2013-04-18       Impact factor: 4.442

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.